minocycline + clindamycin + tretinoin + benzoyl peroxide

This is a **combination regimen** comprising four active agents: **minocycline** (an oral tetracycline-class antibiotic), **clindamycin** (a topical lincosamide antibiotic), **tretinoin** (a topical retinoid), and **benzoyl peroxide** (a topical antibacterial and keratolytic agent). The combination regimen is used for the treatment of moderate to severe **acne vulgaris**. Minocycline acts systemically to inhibit bacterial protein synthesis; clindamycin reduces local cutaneous *Cutibacterium acnes* populations; benzoyl peroxide delivers bactericidal and mild comedolytic effects and reduces antibiotic resistance; tretinoin normalizes follicular epithelial cell turnover to prevent comedone formation and modulate inflammation. Clinical evidence supports the use of this combination to achieve broad-spectrum efficacy, targeting multiple pathogenic factors in acne, with a good safety profile and marked reduction in lesion counts. This regimen is not a single fixed-dose combination product but has been evaluated as coordinated use of constituent agents in a prescribed regimen[5][7].